main-logo

ICD-10 Code C44.1192 | Basal cell carcinoma skin/ left lower eyelid, inc canthus Symptoms, Diagnosis, Billing

Basal cell carcinoma (BCC) is a common skin cancer arising from the basal cells in the epidermis. The left lower eyelid, including the inner canthus, is a frequent site for BCC due to sun exposure. Accurate coding with ICD-10 Code C44.1192 is essential for proper diagnosis, documentation, and billing, facilitating effective treatment and public health reporting.

What is ICD-10 Code C44.1192 for Basal cell carcinoma skin/ left lower eyelid, inc canthus?

ICD-10 Code C44.1192 specifically identifies basal cell carcinoma located on the skin of the left lower eyelid, including the inner canthus. This code is used in clinical documentation and billing to denote the presence of this malignancy, which is crucial for treatment planning and insurance reimbursement.

ICD-10 Code C44.1192 – Clinical Definition and Explanation of Basal cell carcinoma skin/ left lower eyelid, inc canthus

Basal cell carcinoma of the left lower eyelid, including the inner canthus, is primarily caused by prolonged ultraviolet (UV) exposure, leading to abnormal growth of basal cells. This condition can progress if left untreated, necessitating prompt medical intervention.

Key Clinical Features:

  • Typically presents as a pearly or waxy bump on the eyelid.
  • May exhibit ulceration or bleeding.
  • Commonly occurs in fair-skinned individuals with a history of sun exposure.
  • Slow-growing and rarely metastasizes, but can invade local tissues.

ICD-10 Code C44.1192 for Basal cell carcinoma skin/ left lower eyelid, inc canthus – SOAP Notes & Clinical Use

ICD-10 Code C44.1192 is utilized in SOAP notes to document the diagnosis of basal cell carcinoma on the left lower eyelid. It aids in capturing symptoms, assessments, and treatment plans, relevant in both acute and chronic care settings.

What Does ICD-10 Code C44.1192 for Basal cell carcinoma skin/ left lower eyelid, inc canthus Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C44.1192 connects subjective patient reports and objective clinical findings to a formal diagnosis of basal cell carcinoma, ensuring continuity of care and supporting accurate billing and EHR documentation.

Treatment Options for ICD-10 Code C44.1192 – Basal cell carcinoma skin/ left lower eyelid, inc canthus

Timely treatment of basal cell carcinoma is crucial to prevent local invasion and complications.

Antibiotic Therapy:

    Supportive Care:

    • Regular follow-up appointments to monitor for recurrence.
    • Patient education on sun protection and skin care.
    • Wound care post-surgery to promote healing.

    Infection Control:

      How to Document Symptoms of Basal cell carcinoma skin/ left lower eyelid, inc canthus (ICD-10 C44.1192) in SOAP Notes

      Subjective:

      • Patient reports a new growth on the left lower eyelid.
      • Describes the lesion as itchy and occasionally bleeding.
      • History of sun exposure and previous skin cancers.

      Objective:

      • Physical examination reveals a pearly, raised lesion on the left lower eyelid.
      • No lymphadenopathy noted.
      • Dermatoscopic examination shows telangiectasia.
      card-topcard-bottom

      Secure, compliant, and built for trust

      HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

      Learn more
      hipaa-icon

      SOAP Note Guidelines for Diagnosing Basal cell carcinoma skin/ left lower eyelid, inc canthus (ICD-10 Code C44.1192)

      Assessment:

      • Diagnosis: Basal cell carcinoma, left lower eyelid, inc canthus, moderate severity.
      • ICD-10 Code: C44.1192.
      • Contributing factors: History of UV exposure.

      Plan:

      • Refer to dermatology for excisional biopsy.
      • Educate patient on sun protection measures.
      • Schedule follow-up in 2 weeks to discuss biopsy results.

      Treatment & Plan Section for ICD-10 Code C44.1192 – Basal cell carcinoma skin/ left lower eyelid, inc canthus

      • Surgical excision is the primary treatment option.
      • Consider Mohs micrographic surgery for cosmetically sensitive areas.
      • Topical chemotherapy may be indicated for superficial lesions.
      • Regular skin examinations to monitor for new lesions.

      Using ICD-10 Code C44.1192 for Basal cell carcinoma skin/ left lower eyelid, inc canthus in Billing & SOAP Note Compliance

      • Ensure accurate documentation of symptoms and clinical findings.
      • Use C44.1192 in conjunction with procedure codes for surgical interventions.
      • Maintain clear records of patient education and follow-up plans.
      • Document any complications or additional treatments to support billing.

      ICD-10 Code C44.1192 in Medical Billing and Insurance for Basal cell carcinoma skin/ left lower eyelid, inc canthus

      ICD-10 Code C44.1192 is critical for accurate billing in hospital and outpatient settings.

      Billing Notes:

      • Document all relevant clinical findings to support the diagnosis.
      • Use this code in conjunction with procedure codes for surgical interventions.
      • Ensure compliance with payer-specific documentation requirements.

      Common CPT Pairings:

      CPT CodeDescription
      11420Excision, benign skin lesion, face, ears, scalp, neck; excised diameter 0.5 cm or less.
      11421Excision, benign skin lesion, face, ears, scalp, neck; excised diameter 0.6 to 1.0 cm.
      17311Destruction, malignant skin lesion, face, ears, scalp, neck; excised diameter 0.5 cm or less.

      Frequently Asked Questions

      Common Questions About Using ICD-10 Code C44.1192 for Basal cell carcinoma skin/ left lower eyelid, inc canthus

      What are the common symptoms of basal cell carcinoma?

      Common symptoms include a pearly or waxy bump, a flat, scaly patch, or a sore that bleeds or doesn't heal. Patients may also report itching or tenderness in the affected area.

      Is basal cell carcinoma contagious?

      No, basal cell carcinoma is not contagious. It is caused by skin damage from UV radiation and is not spread from person to person.

      How is basal cell carcinoma treated?

      Treatment options include surgical excision, Mohs micrographic surgery, and topical chemotherapy. The choice of treatment depends on the size, location, and type of the carcinoma.

      What is the prognosis for basal cell carcinoma?

      The prognosis for basal cell carcinoma is generally excellent, especially when detected early. Most cases can be effectively treated with minimal risk of recurrence.

      diamond-bg
      diamond-bg

      Get started with your 20 free notes

      Sign up for free
      main-logo

      AI-aided Sudsy Shorthand for ink-free practices

      support@soapsuds.io
      hipaa-logo

      Clinical Notes

      SOAP notes

      DAP notes

      AI medical notes

      © Copyright SOAPsuds 2025. All rights reserved